Cargando…
Rapamycin Promotes the Expansion of Myeloid Cells by Increasing G-CSF Expression in Mesenchymal Stem Cells
Rapamycin, also known as sirolimus, an inhibitor of mammalian target of rapamycin (mTOR), is a regulatory kinase responsible for multiple signal transduction pathways. Although rapamycin has been widely used in treating various hematologic diseases, the effects of rapamycin are still not fully under...
Autores principales: | Li, Minghao, Lan, Yanjie, Gao, Juan, Yuan, Shengnan, Hou, Shuaibing, Guo, Tengxiao, Zhao, Fei, Wang, Yuxia, Yuan, Weiping, Wang, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969869/ https://www.ncbi.nlm.nih.gov/pubmed/35372343 http://dx.doi.org/10.3389/fcell.2022.779159 |
Ejemplares similares
-
Rheb1-Deficient Neutrophils Promote Hematopoietic Stem/Progenitor Cell Proliferation via Mesenchymal Stem Cells
por: Gao, Juan, et al.
Publicado: (2021) -
PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression
por: Yuan, Shengnan, et al.
Publicado: (2021) -
R274X-mutated Phf6 increased the self-renewal and skewed T cell differentiation of hematopoietic stem cells
por: Lan, Yanjie, et al.
Publicado: (2023) -
PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway
por: Hou, Shuaibing, et al.
Publicado: (2023) -
Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells
por: Tan, Zhenya, et al.
Publicado: (2022)